Mycenax Biotech Capital Reinvestment Ratio
Mycenax Biotech capital reinvestment ratio. Mycenax Biotech (4726) has a Capital Reinvestment Ratio of 5.90x as of March 2025, meaning it reinvests 6% of its operating cash flow (NT$14.29 Million) in capital expenditures (NT$84.30 Million). Check Mycenax Biotech total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Mycenax Biotech (2020–2020)
Capital reinvestment ratio of Mycenax Biotech from 2020 to 2020. This chart tracks Mycenax Biotech's Capital Reinvestment Ratio across 1 annual periods. Also explore Mycenax Biotech (4726) net asset momentum to track the company's year-over-year net asset growth rate.
Mycenax Biotech Capital Reinvestment Ratio by Year (2020–2020)
Mycenax Biotech capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see 4726 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.49x | NT$174.17 Million | NT$260.22 Million | — |